Expression of the cellular oxygen sensor PHD2 (EGLN-1) predicts radiation sensitivity in squamous cell cancer of the head and neck

References

• Aebersold D M, Burri P, Beer K T, Laissue J, Djonov V, Greiner R H, Semenza G L. Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Research 2001; 61: 2911–2916
   PubMed Web of Science ®Google Scholar
• Bankfalvi A, Piffko J. Prognostic and predictive factors in oral cancer: The role of the invasive tumour front. Journal of Oral Pathology & Medicine 2000; 29: 291–298
   PubMedGoogle Scholar
• Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. The EMBO Journal 2003; 22: 4082–4090
   PubMed Web of Science ®Google Scholar
• Brizel D M, Dodge R K, Clough R W, Dewhirst M W. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome. Radiotherapy and Oncology 1999; 53: 113–117
   PubMed Web of Science ®Google Scholar
• Brizel D M, Scully S P, Harrelson J M, Layfield L J, Bean J M, Prosnitz L R, Dewhirst M W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research 1996; 56: 941–943
   PubMed Web of Science ®Google Scholar
• Brizel D M, Sibley G S, Prosnitz L R, Scher R L, Dewhirst M W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics 1997; 38: 285–289
   PubMed Web of Science ®Google Scholar
• Broders A C. Practical points on the microscopic grading of carcinoma. New York State Journal of Medicine 1932
   Google Scholar
• Brown J M. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies. Molecular Medicine Today 2000; 6: 157–162
   PubMedGoogle Scholar
• Bruick R K, McKnight S L. A conserved family of Prolyl-4-hydroxylases that modify HIF. Science 2001; 294: 1337–1340
   PubMed Web of Science ®Google Scholar
• Chi J T, Wang Z, Nuyten D S, Rodriguez E H, Schaner M E, Salim A, Wang Y, Kristensen G B, Helland A, Borresen-Dale A L, Giaccia A, Longaker M T, Hastie T, Yang G P, Vijver M J, Brown P O. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. Public Library of Science Medicine 2006; 3: e47
   Google Scholar
• D'Angelo G, Duplan E, Boyer N, Vigne P, Frelin C. Hypoxia up-regulates prolyl hydroxylase activity: A feedback mechanism that limits HIF-1 responses during reoxygenation. Journal of Biological Chemistry 2003; 278: 38183–38187
   PubMed Web of Science ®Google Scholar
• Dunst J, Stadler P, Becker A, Lautenschlager C, Pelz T, Hansgen G, Molls M, Kuhnt T. Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlentherapie und Onkologie 2003; 179: 521–526
   PubMedGoogle Scholar
• Epstein A C, Gleadle J M, McNeill L A, Hewitson K S, O'Rourke J, Mole D R, Mukherji M, Metzen E, Wilson M I, Dhanda A, Tian Y M, Masson N, Hamilton D L, Jaakkola P, Barstead R, Hodgkin J, Maxwell P H, Pugh C W, Schofield C J, Ratcliffe P J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43–54
   PubMed Web of Science ®Google Scholar
• Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill R P. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. Journal of Clinical Oncology 2002; 20: 680–687
   PubMed Web of Science ®Google Scholar
• Graeber T G, Osmanian C, Jacks T, Housman D E, Koch C J, Lowe S W, Giaccia A J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88–91
   PubMed Web of Science ®Google Scholar
• Gray L H, Conger A D, Ebert M, Hornsey S, Scott O C. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. The British Journal of Radiology 1953; 26: 638–648
   PubMed Web of Science ®Google Scholar
• Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research 1996; 56: 4509–4515
   PubMed Web of Science ®Google Scholar
• Hui E P, Chan A T, Pezzella F, Turley H, To K F, Poon T C, Zee B, Mo F, Teo P M, Huang D P, Gatter K C, Johnson P J, Harris A L. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clinical Cancer Research 2002; 8: 2595–2604
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Sakurai H, Hasegawa M, Mitsuhashi N, Takahashi M, Masuda N, Nakajima M, Kitamoto Y, Saitoh J, Nakano T. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. International Journal of Radiation Oncology, Biology, Physics 2004; 60: 513–521
   PubMed Web of Science ®Google Scholar
• Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara J M, Lane W S, Kaelin W G, Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 2001; 292: 464–468
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole D R, Tian Y M, Wilson M I, Gielbert J, Gaskell S J, Kriegsheim A, Hebestreit H F, Mukherji M, Schofield C J, Maxwell P H, Pugh C W, Ratcliffe P J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468–472
   PubMed Web of Science ®Google Scholar
• Jokilehto T, Rantanen K, Luukkaa M, Heikkinen P, Grenman R, Minn H, Kronqvist P, Jaakkola P M. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clinical Cancer Research 2006; 12: 1080–1087
   PubMed Web of Science ®Google Scholar
• Koukourakis M I, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, Talks K, Gatter K C, Harris A L. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2002; 53: 1192–1202
   PubMed Web of Science ®Google Scholar
• Krajewska M, Krajewski S, Epstein J I, Shabaik A, Sauvageot J, Song K, Kitada S, Reed J C. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. The American Journal of Pathology 1996; 148: 1567–1576
   PubMed Web of Science ®Google Scholar
• Kronqvist P, Kuopio T, Collan Y. Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade. British Journal of Cancer 1998; 78: 800–805
   PubMed Web of Science ®Google Scholar
• Kurokawa T, Miyamoto M, Kato K, Cho Y, Kawarada Y, Hida Y, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H. Overexpression of hypoxia-inducible-factor 1alpha (HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. British Journal of Cancer 2003; 89: 1042–1047
   PubMedGoogle Scholar
• Lando D, Peet D J, Whelan D A, Gorman J J, Whitelaw M L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295: 858–861
   PubMed Web of Science ®Google Scholar
• Lindholm P, Valavaara R, Aitasalo K, Kulmala J, Laine J, Elomaa L, Sillanmaki L, Minn H, Grenman R. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: A prospective phase II study. Radiotherapy and Oncology 2006; 78: 146–151
   PubMed Web of Science ®Google Scholar
• Luukkaa M, Minn H, Aitasalo K, Kronqvist P, Kulmala J, Pyrhönen S, Grénman R. Treatment of squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx – an analysis of 174 patients in south western Finland. Acta Oncologica 2003; 42: 756–762
   PubMed Web of Science ®Google Scholar
• Marxsen J H. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochemistry Journal 2004; 381: 761–767
   PubMed Web of Science ®Google Scholar
• Maxwell P H, Dachs G U, Gleadle J M, Nicholls L G, Harris A L, Stratford I J, Hankinson O, Pugh C W, Ratcliffe P J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proceedings of the National Academy of Sciences of the USA 1997; 94: 8104–8109
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Bentzen S M, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris D J, Overgaard J. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiotherapy and Oncology 2005; 77: 18–24
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Hoyer M, Keller J, Nielsen O S, Jensen O M, Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. International Journal of Radiation Oncology, Biology, Physics 1996a; 35: 701–708
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiotherapy and Oncology 2000; 57: 39–43
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology 1996b; 41: 31–39
   PubMed Web of Science ®Google Scholar
• O-charoenrat P, Pillai G, Patel S, Fisher C, Archer D, Eccles S, Rhys-Evans P. Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncology 2003; 39: 386–390
   PubMed Web of Science ®Google Scholar
• Oken M M, Creech R H, Tormey D C, Horton J, Davis T E, McFadden E T, Carbone P P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 1982; 5: 649–655
   PubMed Web of Science ®Google Scholar
• Reynolds T Y, Rockwell S, Glazer P M. Genetic instability induced by the tumor microenvironment. Cancer Research 1996; 56: 5754–5757
   PubMed Web of Science ®Google Scholar
• Rudat V, Stadler P, Becker A, Vanselow B, Dietz A, Wannenmacher M, Molls M, Dunst J, Feldmann H J. Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlentherapie und Onkologie 2001; 177: 462–468
   PubMed Web of Science ®Google Scholar
• Schindl M, Schoppmann S F, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G. and the Austrian Breast and Colorectal Cancer Study Group. 2002. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clinical Cancer Research 2002; 8: 1831–1837
   PubMed Web of Science ®Google Scholar
• Scully R E, Bonfiglo T A, Kurman R J, Silverberg S G, Wilkinson E J. Histological typing of female genital tract tumours. World Health Organization International Histological Classification of Tumours2nd ed. Springer-Verlag, Berlin 1994
   Google Scholar
• Semenza G L. Targeting HIF-1 for cancer therapy. National Review of Cancer 2003; 3: 721–732
   PubMed Web of Science ®Google Scholar
• Semenza G L. Hypoxia-inducible factor 1: Master regulator of O2 homeostasis. Current Opinion in Genetics & Development 1998; 8: 588–594
   PubMed Web of Science ®Google Scholar
• Shanmugaratnam K, Sobin L H. Histological typing of tumours of the upper respiratory tract and ear. International Histological Classification of Tumors2nd ed. Springer Verlag, Berlin 1991
   Google Scholar
• Shim V, Gauthier M L, Sudilovsky D, Mantei K, Chew K L, Moore D H, Cha I, Tlsty T D, Esserman L J. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Research 2003; 63: 2347–2350
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843–845
   PubMed Web of Science ®Google Scholar
• Sobin L H, Wittekind C. TNM classification of malignant tumours. International Union Against Cancer (IUCC)6th ed. Wiley-Liss, New York 2002
   Google Scholar
• Soslow R A, Dannenberg A J, Rush D, Woerner B M, Khan K N, Masferrer J, Koki A T. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000; 89: 2637–2645
   PubMed Web of Science ®Google Scholar
• Theodoropoulos V E, Lazaris A C, Kastriotis I, Spiliadi C, Theodoropoulos G E, Tsoukala V, Patsouris E, Sofras F. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU International 2005; 95: 425–431
   PubMed Web of Science ®Google Scholar
• Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Research 2000; 20: 1527–1533
   PubMed Web of Science ®Google Scholar
• Welkoborsky H J, Hinni M, Dienes H P, Mann W J. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. The Annals of Otology, Rhinology, and Laryngology 1995; 104: 503–510
   PubMed Web of Science ®Google Scholar
• Wenger R H. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. The FASEB Journal: Official publication of the Federation of American Societies for Experimental Biology 2002; 16: 1151–1162
   PubMed Web of Science ®Google Scholar
• Williams K J, Telfer B A, Xenaki D, Sheridan M R, Desbaillets I, Peters H J, Honess D, Harris A L, Dachs G U, van der Kogel A, Stratford I J. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiotherapy and Oncology 2005; 75: 89–98
   PubMed Web of Science ®Google Scholar
• Yu F, White S B, Zhao Q, Lee F S. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proceedings of the National Academy of Sciences of the USA 2001; 98: 9630–9635
   PubMed Web of Science ®Google Scholar
• Yuan J, Glazer P M. Mutagenesis induced by the tumor microenvironment. Mutation Research 1998; 400: 439–446
   PubMed Web of Science ®Google Scholar